WOBURN, Mass., June 12 /PRNewswire/ -- AdvanDx announces that at the recent American Society for Microbiology (ASM) meeting in Orlando, Florida, EVIGENE(TM) kits (http://www.evigene-test.com) for detecting specific antibiotic resistance, virulence, and toxicity markers such as methicillin- resistance, vancomycin-resistance, PVL and TSST-1 in Staphylococcus aureus and enterococci, were launched for research use only in the United States. EVIGENE was officially launched for clinical use in Europe in April, 2006 at the 16th European Congress on Clinical Microbiology and Infectious Diseases (ECCMID) conference in Nice, France.
